| 200954-100MG |
|
NA |
(5aR,10bS)-5a,10b-Dihydro-5-(9-anthracene)-2-(2,4,6-tribromophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C32H21Br3N3O·BF4 |
|
|
|
| 200953-100MG |
|
NA |
(5aS,10bR)-5a,10b-Dihydro-5-(9-phenanthrene)-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C33H21F3Br2N3O·BF4 |
|
|
|
| 200952-100MG |
|
NA |
(5aR,10bS)-5a,10b-Dihydro-5-(9-phenanthrene)-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C33H21F3Br2N3O·BF4 |
|
|
|
| 200937-100MG |
|
NA |
(5aS,10bR)-5a,10b-Dihydro-5-(1-naphthalene)-2-(2,4,6-tribromophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C28H19Br3N3O·BF4 |
|
|
|
| 200951-100MG |
|
NA |
(5aR,10bS)-5a,10b-Dihydro-5-(1-naphthalenyl)-2-(2,4,6-tribromophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C28H19Br3N3O·BF4 |
|
|
|
| 200936-100MG |
|
NA |
(5aS,10bR)-5a,10b-Dihydro-5-phenyl-2-(2,4,6-tribromophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C24H17Br3N3O·BF4 |
|
|
|
| 200950-100MG |
|
NA |
(5aR,10bS)-5a,10b-Dihydro-5-phenyl-2-(2,4,6-tribromophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C24H17Br3N3O·BF4 |
|
|
|
| 200935-100MG |
|
NA |
(5aS,10bR)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C19H13F3Br2N3O·BF4 |
|
|
|
| 200949-100MG |
|
NA |
(5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C19H13F3Br2N3O·BF4 |
|
|
|
| 200929-25G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
25G |
C5H12N2O•HCl |
|
|
|
| 200929-5G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
5G |
C5H12N2O•HCl |
|
|
|
| 200929-1G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
1G |
C5H12N2O•HCl |
|
|
|
| 200927-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
1G |
C45H55O4P |
|
|
|
| 200927-100MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
100MG |
C45H55O4P |
|
|
|
| 200927-25MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C45H55O4P |
|
|
|
| 200926-1G |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
1G |
C45H55O4P |
|
|
|
| 200926-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
100MG |
C45H55O4P |
|
|
|
| 200926-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C45H55O4P |
|
|
|
| 200821-100MG |
|
NA |
(5R,6S)-5,6-Diphenyl-2-(2,4,6-tribromophenyl)-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C23H17Br3N3O•BF4 |
|
|
|
| 200820-100MG |
|
NA |
(S)-5-(Hydroxy-diphenylmethyl)-2-(2,4,6-tribromophenyl)-6,7-dihydro-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C24H19Br3N3O•BF4 |
|
|
|
